Pro-Dex, Inc. (PDEX)

USD 45.73

(-5.61%)

Revenue Summary of Pro-Dex, Inc.

  • Pro-Dex, Inc.'s latest annual revenue in 2024 was 53.84 Million USD , up 16.83% from previous year.
  • Pro-Dex, Inc.'s latest quarterly revenue in 2024 FY was 53.84 Million USD , up 16.83% from previous quarter.
  • Pro-Dex, Inc. reported a annual revenue of 46.08 Million USD in annual revenue 2023, up 9.62% from previous year.
  • Pro-Dex, Inc. reported a annual revenue of 42.04 Million USD in annual revenue 2022, up 10.55% from previous year.
  • Pro-Dex, Inc. reported a quarterly revenue of 12.58 Million USD for 2024 Q2, up 5.44% from previous quarter.
  • Pro-Dex, Inc. reported a quarterly revenue of 11.93 Million USD for 2024 Q1, up 12.21% from previous quarter.

Annual Revenue Chart of Pro-Dex, Inc. (2024 - 1989)

Historical Annual Revenue of Pro-Dex, Inc. (2024 - 1989)

Year Revenue Revenue Growth
2024 53.84 Million USD 16.83%
2023 46.08 Million USD 9.62%
2022 42.04 Million USD 10.55%
2021 38.02 Million USD 9.17%
2020 34.83 Million USD 28.2%
2019 27.17 Million USD 20.95%
2018 22.46 Million USD 2.38%
2017 21.94 Million USD 8.86%
2016 20.15 Million USD 50.62%
2015 13.38 Million USD 23.78%
2014 10.81 Million USD -11.73%
2013 12.24 Million USD -29.02%
2012 17.25 Million USD -36.34%
2011 27.1 Million USD 16.79%
2010 23.21 Million USD 9.89%
2009 21.12 Million USD -15.94%
2008 25.12 Million USD 16.52%
2007 21.56 Million USD 26.39%
2006 17.06 Million USD 23.33%
2005 13.83 Million USD -2.58%
2004 14.2 Million USD 18.43%
2003 11.99 Million USD 13.91%
2002 10.52 Million USD -29.09%
2001 14.84 Million USD -44.34%
2000 26.67 Million USD 45.4%
1999 18.34 Million USD -19.01%
1998 22.64 Million USD 17.96%
1997 19.2 Million USD -7.69%
1996 20.8 Million USD 131.11%
1995 9 Million USD 11.11%
1994 8.1 Million USD 15.71%
1993 7 Million USD 32.08%
1992 5.3 Million USD 152.38%
1991 2.1 Million USD -4.55%
1990 2.2 Million USD 10.0%
1989 2 Million USD -25.93%

Peer Revenue Comparison of Pro-Dex, Inc.

Name Revenue Revenue Difference
Akoya Biosciences, Inc. 96.63 Million USD 44.28%
AngioDynamics, Inc. 303.91 Million USD 82.283%
AtriCure, Inc. 399.24 Million USD 86.514%
Avinger, Inc. 7.65 Million USD -603.659%
Azenta, Inc. 665.07 Million USD 91.904%
BioLife Solutions, Inc. 143.27 Million USD 62.418%
The Cooper Companies, Inc. 3.59 Billion USD 98.502%
Daxor Corporation 1.28 Million USD -4104.871%
Ekso Bionics Holdings, Inc. 18.27 Million USD -194.568%
Femasys Inc. 1.07 Million USD -4922.902%
GlucoTrack, Inc. - USD -Infinity%
Harvard Bioscience, Inc. 112.25 Million USD 52.032%
Hologic, Inc. 4.03 Billion USD 98.664%
ICU Medical, Inc. 2.25 Billion USD 97.617%
Intuitive Surgical, Inc. 7.12 Billion USD 99.244%
KORU Medical Systems, Inc. 28.51 Million USD -88.809%
LeMaitre Vascular, Inc. 193.48 Million USD 72.171%
Innovative Eyewear, Inc. 1.15 Million USD -4572.016%
Innovative Eyewear, Inc. 1.15 Million USD -4572.016%
Masimo Corporation 2.04 Billion USD 97.371%
Microbot Medical Inc. - USD -Infinity%
Meihua International Medical Technologies Co., Ltd. 97.09 Million USD 44.547%
Merit Medical Systems, Inc. 1.25 Billion USD 95.718%
Nephros, Inc. 14.23 Million USD -278.171%
NovoCure Limited 509.33 Million USD 89.429%
NEXGEL, Inc. 4.08 Million USD -1216.801%
NEXGEL, Inc. 4.08 Million USD -1216.801%
Singular Genomics Systems, Inc. 2.91 Million USD -1749.674%
OraSure Technologies, Inc. 405.47 Million USD 86.721%
Pulse Biosciences, Inc. - USD -Infinity%
Predictive Oncology Inc. 1.78 Million USD -2924.786%
Precision Optics Corporation, Inc. 19.1 Million USD -181.842%
QuidelOrtho Corporation 2.99 Billion USD 98.204%
Repligen Corporation 638.76 Million USD 91.571%
Sanara MedTech Inc. 64.98 Million USD 17.15%
STAAR Surgical Company 322.41 Million USD 83.3%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 50.22 Million USD -7.208%
DENTSPLY SIRONA Inc. 3.96 Billion USD 98.642%
Jin Medical International Ltd. 19.82 Million USD -171.645%